183 related articles for article (PubMed ID: 5300283)
1. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
Rizzo A; Magalhães M; Moura N
Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
[No Abstract] [Full Text] [Related]
2. [Depot drugs in the treatment of resistant forms of pulmonary tuberculosis. The experience of the Conjunto Sanatorial Octávio de Freitas (Recife)].
Rizzo A; Moura N; Magalhães M; Antunes G; Campelo C
Rev Bras Med; 1966 Dec; 23(12):850-2. PubMed ID: 5999012
[No Abstract] [Full Text] [Related]
3. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
[No Abstract] [Full Text] [Related]
4. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
[No Abstract] [Full Text] [Related]
5. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
Zunić D
Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
[No Abstract] [Full Text] [Related]
6. [Autonomic drug therapy with delayed action drugs in pulmonary tuberculosis (chronic-drug therapy resistant patients, without immediate surgical possibilities)].
Bethlem N; Mendes W
Hospital (Rio J); 1968 Jul; 74(1):1-5. PubMed ID: 5305552
[No Abstract] [Full Text] [Related]
7. Duration of application and change of a regimen with secondary drugs.
Oka S; Takase Y; Kato S
Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926
[No Abstract] [Full Text] [Related]
8. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
[No Abstract] [Full Text] [Related]
9. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
Rizzo A; Magalhães M; Moura N
Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
[No Abstract] [Full Text] [Related]
10. [Administration of reserve antitubercular drugs in a single daily dose].
Bek E; Bukalska Z; Zachara A
Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
[No Abstract] [Full Text] [Related]
11. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Fegiz G
Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
[No Abstract] [Full Text] [Related]
12. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
[No Abstract] [Full Text] [Related]
13. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
Ibarra JP; Piñeyro J; Trenchi A; Tarallo NH; Lanne de Farriols ME; Cuñarro de Gimeno G; Fernández Latorre I
Hoja Tisiol; 1967; 24(1):5-88. PubMed ID: 4308762
[No Abstract] [Full Text] [Related]
14. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
[No Abstract] [Full Text] [Related]
15. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with drug-resistance in economically developed countries.
Crofton J
Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
18. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
Bignall JR
Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
[No Abstract] [Full Text] [Related]
19. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
[No Abstract] [Full Text] [Related]
20. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
Zanotelli F; Perusi O
G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
